Advantage plans do a better job than standalone Part D policies, albeit with important gap ...

Much of President Donald Trump’s campaign promises to lower drug prices in the U.S. | According to a review by The New York Times, the MFN prices offered on certain drugs through the government's ...

AbbVie (ABBV) dropped 4.69% after FDA approved J&J's Icotyde psoriasis pill, creating fresh competition for blockbuster drug ...

The TrumpRx website claims to offer the best prices for medications. Here’s where Americans still pay more — and much more.

AbbVie slips below its 50-day SMA, signaling short-term weakness, but strong drug growth and a solid long-term uptrend may keep investors holding or buying dips ...

The White House’s direct-to-consumer (DTC) platform, TrumpRx, is steadily expanding its catalogue, with products from GSK and Amgen the latest to join the collection of drugs offered through the pr | ...

Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.’s share was trading at ...

AUSTIN (KXAN) — The war in Iran continues to disrupt the global supply chain. Cargo ships stalled in the Gulf may lead to higher fuel prices, but also prescription drugs. KXAN’s Sally Hernandez talked ...

AbbVie (ABBV) stock felt some downward pressure despite reporting better-than-expected fourth-quarter results on Feb. 4. AbbVie beat estimates for both earnings and sales and also issued an upbeat ...